Are we there yet? 40 years of successes and challenges for children and adolescents living with HIV.

Vreeman, Rachel C; Rakhmanina, Natella Y; Nyandiko, Winstone M; Puthanakit, Thanyawee; Kantor, Rami

Vreeman, Rachel C; Rakhmanina, Natella Y; Nyandiko, Winstone M; Puthanakit, Thanyawee; Kantor, Rami.

Vreeman RC; Department of Global Health and Health System Design, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Rakhmanina NY; Arnhold Institute for Global Health, New York, NY, USA.
Nyandiko WM; Division of Infectious Diseases, Children's National Hospital, Washington, DC, USA.
Puthanakit T; Department of Pediatrics, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Kantor R; Technical Strategies and Innovation, Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA.

J Int AIDS Soc ; 24(6): e25759, 2021 06.

Article in English | MEDLINE | ID: covidwho-1286124

Subject(s)

Anti-HIV Agents; HIV Infections; Adolescent; Anti-HIV Agents/therapeutic use; Child; HIV Infections/drug therapy; HIV Infections/epidemiology; Humans; Viral Load

Keywords

HIV; adolescents; antiretroviral therapy; children; paediatrics; resistance

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents Type of study: Observational study Limits: Adolescent / Child / Humans Language: English Journal: J Int AIDS Soc Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2021 Document Type: Article Affiliation country: Jia2.25759

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google